Loading...
CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer
Background: The development of molecular targeted therapies, such as EGFR-TKIs, has positively impacted the management of EGFR mutated NSCLC. However, patients with innate and acquired resistance to EGFR-TKIs still face limited effective therapeutic options. Statins are the most frequently prescribe...
Na minha lista:
| Udgivet i: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ivyspring International Publisher
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6735519/ https://ncbi.nlm.nih.gov/pubmed/31534543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.35805 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|